Literature DB >> 31172568

Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag.

Bruno Fattizzo1, Francesca Cavallaro1, Giulia Milesi1, Wilma Barcellini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31172568     DOI： 10.1002/ajh.25550

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study.

Authors:  Wenrui Yang; Xin Zhao; Guangsheng He; Hong Chang; Bing Han; Sujun Gao; Shunqing Wang; Tong Chen; Fei Li; Yi Wang; Xiaoyan Ge; Rong Fu; Zheng Ge; Yingmei Li; Hong Liu; Xinjian Liu; Miao Miao; Liansheng Zhang; Fengkui Zhang
Journal:  Ann Hematol       Date:  2022-10-11       Impact factor: 4.030

2.  Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia.

Authors:  Yihong Guan; Metis Hasipek; Dongxu Jiang; Anand D Tiwari; Dale R Grabowski; Simona Pagliuca; Sunisa Kongkiatkamon; Bhumika Patel; Salendra Singh; Yvonne Parker; Thomas LaFramboise; Daniel Lindner; Mikkael A Sekeres; Omar Y Mian; Yogen Saunthararajah; Jaroslaw P Maciejewski; Babal K Jha
Journal:  J Clin Invest       Date:  2022-02-15       Impact factor: 14.808

3.  Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature.

Authors:  Marta Bortolotti; Loredana Pettine; Anna Zaninoni; Giorgio Alberto Croci; Wilma Barcellini; Bruno Fattizzo
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-30

Review 4.  Novel therapeutic choices in immune aplastic anemia.

Authors:  Phillip Scheinberg
Journal:  F1000Res       Date:  2020-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.